Onkos Molecular Diagnostics

Health, Wellness & Fitness - Ribeirão Preto, São Paulo, Brazil

Onkos Molecular Diagnostics Employees
Suzana Araujo

Analista de Laboratorio

Contact Suzana Araujo

Andrei Oliveira

Analista Pleno de Pesquisa e Desenvolvimento

Contact Andrei Oliveira

Raquel Santos

Líder de Atendimento, Logística e Laboratórios Parceiros

Contact Raquel Santos

Leonardo Joaquim

Analista de Produção de Conteúdo e Design

Contact Leonardo Joaquim

Mirela Prates

Analista de Laboratório Pleno

Contact Mirela Prates

Isabela Morales

Analista de pesquisa e desenvolvimento

Contact Isabela Morales

View All Onkos Molecular Diagnostics Employees Contact All Onkos Molecular Diagnostics Employees
Onkos Molecular Diagnostics Details

Onkos is Latin America´s leading startup company provider of proprietary gene expression-based diagnostic tests that is focused on providing answers to diagnostic uncertainties in Oncology by avoiding unnecessary procedures. We guide informed clinical decisions to enable not only the best patient management available but also healthcare providers efficiencies and savings. Our Gene Expression Profiling platform merges cutting-edge technologies of molecular biology and artificial intelligence tools to create molecular classifiers that are translated into actionable results to unlock the best care for cancer patients. Our current portfolio is composed of the two first gene expression-based tests developed and applied on clinical routine in the southern hemisphere: a. mir-THYpe®, which is a microRNA-based molecular classifier for thyroid nodules with indeterminate cytology. To date, we are driving a revolution with a dramatic reduction in unnecessary thyroid surgeries. The validation study showed a 96% NPV and the test is performed using the readily available smear slides already prepared for prior cytology test.b. TOT- Tumor Origin Test, which is an mRNA-based molecular classifier for Metastatic Cancers with Unknown Primary site. We are providing data that can help physicians with treatment decisions resulting in the patient's best care. The test evaluates the expression profiling generated by a panel of 95 genes and compares the genetic signatures with a database of 4400 known primary cancers, divided into 25 cancer types. We have licensed this test patent and commercialization rights to Fleury Group, one of the largest laboratory networks in Latin America.Onkos is part of the two main Healthcare Innovation Centers in Latin America:a. The Eretz.bio hub, which is linked to the main private hospital in Latin America – Albert Einstein Hospitalb. The SUPERA Technology Park, which is linked to the main university in Latin America – Univesity of São Paulo (USP)

Onkos Molecular Diagnostics logo, Onkos Molecular Diagnostics contact details
Employees: 19
HQ:
Location: Ribeirão Preto, São Paulo, Brazil
Revenue:
Onkos Molecular Diagnostics Technologies
Email Providers

Gmail

Load Balancers

Varnish

CMS

WordPress.org

Other

Mobile Friendly

View All Technologies Used At Onkos Molecular Diagnostics

Contacting Onkos Molecular Diagnostics: Connect with Executives and Employees

Get in Touch with Onkos Molecular Diagnostics Executives and Employees

Connecting with Onkos Molecular Diagnostics's Executives and Workforce

Accessing Contact Information for Onkos Molecular Diagnostics Executives

Connecting with Onkos Molecular Diagnostics: Reach Out to Their Team

Discover How to Contact Onkos Molecular Diagnostics Executives and Staff

Looking to connect with Onkos Molecular Diagnostics executives or employees?

Seeking to Get in Touch with Onkos Molecular Diagnostics Executives or Staff?

Want to Reach Out to Onkos Molecular Diagnostics Executives or Team Members?

In Search of Contact Details for Onkos Molecular Diagnostics Professionals?

Connecting with Onkos Molecular Diagnostics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z